Latest KFF Health News Stories
KFF Health News' 'What the Health?': Alabama Court Rules Embryos Are Children. What Now?
In a first-of-its-kind ruling, the Alabama Supreme Court has determined that embryos created for in vitro fertilization procedures are legally people. The decision has touched off massive confusion about potential ramifications, and the University of Alabama-Birmingham has paused its IVF program. Meanwhile, former President Donald Trump is reportedly planning to endorse a national 16-week abortion ban, while his former administration officials are planning further reproductive health restrictions for a possible second term. Lauren Weber of The Washington Post, Rachana Pradhan of KFF Health News, and Victoria Knight of Axios join KFF Health News’ Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week that they think you should read, too.
Cómo impactaría una segunda presidencia de Trump en la atención de salud
Intentar pronosticar las prioridades de Trump en un segundo mandato es aún más difícil ya que cambia frecuentemente de posición sobre los temas, y lo hace muchas veces.
What Would a Second Trump Presidency Look Like for Health Care?
Health policy during Donald Trump’s tenure was dominated by covid-19 and a failed effort to repeal and replace the Affordable Care Act. His appointments to the Supreme Court led to the end of national abortion rights, and he took steps to increase hospital price transparency and improve care for veterans.
Covid Relief Payments Triggered Feds to Demand Money Back From Social Security Recipients
Some Social Security beneficiaries say the government is clawing back benefits after they received covid stimulus payments that were supposed to be exempt from asset limits.
Trump Misplaced Blame When He Said Drug Shortages Were Biden’s Fault
Former President Donald Trump, who’s running for another term in the White House, recently blamed drug shortages on his successor, President Joe Biden. Our findings don’t align with Trump’s claims; by some measures, drug shortages increased more on Trump’s watch than on Biden’s.
Many Refugees Dealing With Trauma Face Obstacles to Mental Health Care
Refugees are arriving in the U.S. in greater numbers after a 40-year low, prompting some health professionals to rethink ways to provide culturally competent care amid a shortage of mental health services.
La salud de los inmigrantes se quiebra, y empeora, mientras esperan en refugios fronterizos
La espera, que puede durar meses, hace que algunos migrantes desarrollen problemas de salud. Han aumentado las dolencias crónicas, como la hipertensión o la diabetes.
Shelter Sickness: Migrants See Health Problems Linger and Worsen While Waiting at the Border
U.S. immigration policies, an increasing number of migrants, and the covid-19 pandemic have led to the growth of the Mexican shelter system, in which people are getting sick and medical care is limited.
KHN’s ‘What the Health?’: Washington’s Slow Churn
Stemming gun violence is back on the legislative agenda following three mass shootings in less than a month, but it’s hard to predict success when so many previous efforts have failed. Meanwhile, lawmakers must soon decide if they will extend current premium subsidies for those buying health insurance under the Affordable Care Act, and the Biden administration acts, belatedly, on Medicare premiums. Margot Sanger-Katz of the New York Times, Sandhya Raman of CQ Roll Call, and Rachel Cohrs of Stat News join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN’s Michelle Andrews, who reported and wrote the latest KHN-NPR “Bill of the Month” episode about a too-common problem: denial of no-cost preventive care for a colonoscopy under the Affordable Care Act.
Why Cheap, Older Drugs That Might Treat Covid Never Get Out of the Lab
The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for covid. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.
Surprise-Billing Rule ‘Puts a Thumb on the Scale’ to Keep Arbitrated Costs in Check
Patients soon will not have to worry about the prospect of these often-costly unexpected bills, a federal law promises. Some experts say the new policy could also slow the growth of health insurance premiums.
Apple, Bose and Others Pump Up the Volume on Hearing Aid Options, Filling Void Left by FDA
A 2017 law designed to help lower the cost of hearing aids mandated that federal officials set rules for a new class of devices consumers could buy without needing to see an audiologist. But those regulations are still on hold.
Feds to Nix Work Requirements in Montana Medicaid Expansion Program
State health officials say the federal government will likely reject any work or community engagement requirements, which were key to Republican lawmakers agreeing to extend the program that insures 100,000 low-income Montana adults.
2+2=? Senate Uses Murky Math as It Shelves Drug Pricing Rule to Fund Infrastructure
The Medicare rule, designed by the Trump administration to take money away from drug industry brokers and provide refunds to patients, has not been implemented. But budget analysts say if it were, it would cost the government money. So senators are pushing the rule aside and claiming to save billions of dollars, which they want to use instead on new projects.
Hospital Prices Must Now Be Transparent. For Many Consumers, They’re Still Anyone’s Guess.
A Trump administration rule mandating that hospitals disclose true prices on their websites took effect this year. But compliance is spotty and even when the data is public, it’s hard to find and understand.
KHN’s ‘What the Health?’: Un-Trumping the ACA
The Biden administration is moving to undo many of the changes the Trump administration made to the enrollment process for the Affordable Care Act to encourage more people to sign up for health insurance. Meanwhile, Congress is opening investigations into the controversial approval by the Food and Drug Administration of an expensive drug that might (or might not) slow the progression of Alzheimer’s disease. Joanne Kenen of Politico, Kimberly Leonard of Insider and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Marshall Allen of ProPublica about his new book, “Never Pay the First Bill: And Other Ways to Fight the Health Care System and Win.”
KHN’s ‘What the Health?’: Picking Up the Pace of Undoing Trump Policies
The Biden administration has started to speed efforts to reverse health policies forged under Donald Trump. Most recently, the administration overturned a ban on fetal tissue research and canceled a last-minute extension of a Medicaid waiver for Texas. That latter move may delay the Senate confirmation of President Joe Biden’s nominee to head the Medicare and Medicaid programs, as Sen. John Cornyn (R-Texas) seeks to fight back. Anna Edney of Bloomberg News, Rachel Cohrs of Stat and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
FDA Seeks a New Way to Review Old Drugs Without Causing Prices to Soar
A misguided federal program called the Unapproved Drugs Initiative, which put the FDA’s stamp of approval on old drugs, led to higher prices. It’s scrapped. So now what?
Biden Moves to Overturn Trump Birth Control Rules
Return to pre-Trump policy is second win of the week for abortion-rights backers.
Redfield Joins Big Ass Fans, Which Promotes Controversial Covid-Killing Technology
Dr. Robert Redfield, Trump’s CDC director, lends his scientific credibility to its Clean Air Systems subsidiary, which touts a “virus-killing ion technology” added to its fans. But indoor air quality experts question whether some of its technology works in the real world.
